All insmed articles
-
Business
AstraZeneca sheds multiple drugs
Spate of licensing deals for non-core products as firm further tightens R&D focus
2016-10-25T17:30:00Z
Spate of licensing deals for non-core products as firm further tightens R&D focus
Site powered by Webvision Cloud